Lucid Diagnostics, Inc. (LUCD)
1.36
-0.02
(-1.45%)
USD |
NASDAQ |
Feb 20, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Lucid Diagnostics EPS Diluted (Quarterly) : -0.0961 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PAVmed, Inc. | -8.807 |
| Celldex Therapeutics, Inc. | -1.009 |
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.0952 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.40M |
| Revenue (Quarterly) | 1.211M |
| Total Expenses (Quarterly) | 11.61M |
| Enterprise Value | 209.57M |
| Gross Profit Margin (Quarterly) | -58.30% |
| Profit Margin (Quarterly) | -858.5% |
| Earnings Yield | -65.96% |
| Normalized Earnings Yield | -59.97 |